RHC:ASXRamsay Health Care Limited Analysis

Ramsay Health Care (RHC) is trading at AUD 39.49, comfortably above its 20‑day SMA (37.76) and the calculated DCF fair value of AUD 15.34, indicating a substantial premium. The stock sits near its technical resistance of AUD 39.75, with a bullish MACD histogram (+0.31) but an RSI of 62 that hints at overbought conditions. Valuation metrics reinforce the premium: a trailing PE of 31.34 versus an industry average of 24.10 and a forward PE of 24.06, while the dividend yield of 2.15% is backed by a 63% payout ratio.
Fundamentally, the company shows solid revenue growth (≈9.7%) and modest margins (gross 11.9%, operating 5.6%), but it carries an alarming debt‑to‑equity ratio of over 200, with total debt (~AUD 11.9 bn) dwarfing cash holdings (AUD 0.47 bn). The volatility over the past 30 days is high at 22.7%, though beta is modest (≈0.42), and the market sentiment is in “Extreme Greed” territory (Fear & Greed Index 91.46).